Cargando…

A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models

C57BL/6J (BL6J) and C57BL/6N (BL6N) inbred substrains are most widely used to understand the pathological roles of target molecules in a variety of diseases, including non-alcoholic steatohepatitis (NASH), based on transgenic mouse technologies. There are notable differences in the metabolic phenoty...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawashita, Eri, Ishihara, Keiichi, Nomoto, Madoka, Taniguchi, Mika, Akiba, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338790/
https://www.ncbi.nlm.nih.gov/pubmed/30659241
http://dx.doi.org/10.1038/s41598-018-36862-7
_version_ 1783388495204581376
author Kawashita, Eri
Ishihara, Keiichi
Nomoto, Madoka
Taniguchi, Mika
Akiba, Satoshi
author_facet Kawashita, Eri
Ishihara, Keiichi
Nomoto, Madoka
Taniguchi, Mika
Akiba, Satoshi
author_sort Kawashita, Eri
collection PubMed
description C57BL/6J (BL6J) and C57BL/6N (BL6N) inbred substrains are most widely used to understand the pathological roles of target molecules in a variety of diseases, including non-alcoholic steatohepatitis (NASH), based on transgenic mouse technologies. There are notable differences in the metabolic phenotypes, including glucose tolerance, between the BL6J and BL6N substrains, but the phenotypic differences in NASH are still unknown. We performed a comparative analysis of the two mouse substrains to identify the pathological phenotypic differences in NASH models. In the CCl(4)-induced NASH model, the BL6J mice exhibited a more severe degree of oxidative stress and fibrosis in the liver than the BL6N mice. In contrast, in the high-fat diet-induced NASH model, more accumulation of hepatic triglycerides but less weight gain and liver injury were noted in the BL6J mice than in the BL6N mice. Our findings strongly suggest caution be exercised with the use of unmatched mixed genetic background C57BL6 mice for studies related to NASH, especially when generating conditional knockout C57BL6 mice.
format Online
Article
Text
id pubmed-6338790
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63387902019-01-23 A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models Kawashita, Eri Ishihara, Keiichi Nomoto, Madoka Taniguchi, Mika Akiba, Satoshi Sci Rep Article C57BL/6J (BL6J) and C57BL/6N (BL6N) inbred substrains are most widely used to understand the pathological roles of target molecules in a variety of diseases, including non-alcoholic steatohepatitis (NASH), based on transgenic mouse technologies. There are notable differences in the metabolic phenotypes, including glucose tolerance, between the BL6J and BL6N substrains, but the phenotypic differences in NASH are still unknown. We performed a comparative analysis of the two mouse substrains to identify the pathological phenotypic differences in NASH models. In the CCl(4)-induced NASH model, the BL6J mice exhibited a more severe degree of oxidative stress and fibrosis in the liver than the BL6N mice. In contrast, in the high-fat diet-induced NASH model, more accumulation of hepatic triglycerides but less weight gain and liver injury were noted in the BL6J mice than in the BL6N mice. Our findings strongly suggest caution be exercised with the use of unmatched mixed genetic background C57BL6 mice for studies related to NASH, especially when generating conditional knockout C57BL6 mice. Nature Publishing Group UK 2019-01-18 /pmc/articles/PMC6338790/ /pubmed/30659241 http://dx.doi.org/10.1038/s41598-018-36862-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kawashita, Eri
Ishihara, Keiichi
Nomoto, Madoka
Taniguchi, Mika
Akiba, Satoshi
A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models
title A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models
title_full A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models
title_fullStr A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models
title_full_unstemmed A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models
title_short A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models
title_sort comparative analysis of hepatic pathological phenotypes in c57bl/6j and c57bl/6n mouse strains in non-alcoholic steatohepatitis models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338790/
https://www.ncbi.nlm.nih.gov/pubmed/30659241
http://dx.doi.org/10.1038/s41598-018-36862-7
work_keys_str_mv AT kawashitaeri acomparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT ishiharakeiichi acomparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT nomotomadoka acomparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT taniguchimika acomparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT akibasatoshi acomparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT kawashitaeri comparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT ishiharakeiichi comparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT nomotomadoka comparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT taniguchimika comparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels
AT akibasatoshi comparativeanalysisofhepaticpathologicalphenotypesinc57bl6jandc57bl6nmousestrainsinnonalcoholicsteatohepatitismodels